Ursolic acid improves the bacterial community mapping of the intestinal tract in liver fibrosis mice
Open Access
Abstract
Liver fibrosis often appears in chronic liver disease, with extracellular matrix (ECM) deposition as the main feature. Due to the presence of the liver-gut axis, the destruction of intestinal homeostasis is often accompanied by the development of liver fibrosis. The inconsistent ecological environment of different intestinal sites may lead to differences in the microbiota. The traditional Chinese medicine ursolic acid (UA) has been proven to protect the liver from fibrosis. We investigated the changes in the microbiota of different parts of the intestine during liver fibrosis and the effect of UA on these changes based on high-throughput sequencing technology. Sequencing results suggest that the diversity and abundance of intestinal microbiota decline and the composition of the microbiota is disordered, the potentially beneficial Firmicutes bacteria are reduced, and the pathways for functional prediction are changed in the ilea and anal faeces of liver fibrosis mice compared with normal mice. However, in UA-treated liver fibrosis mice, these disorders improved. It is worth noting that the bacterial changes in the ilea and anal faeces are not consistent. In conclusion, in liver fibrosis, the microbiota of different parts of the intestines have different degrees of disorder, and UA can improve this disorder. This may be a potential mechanism for UA to achieve anti-fibrosis. This study provides theoretical guidance for the UA targeting of intestinal microbiota for the treatment of liver fibrosis.Keywords
All Related Versions
Funding Information
- National Natural Science Foundation of China (81960120)
- “Gan-po talent 555” Project of Jiangxi Province
This publication has 44 references indexed in Scilit:
- Hepatic Stellate Cells and Liver Fibrosis2013
- Bacterial translocation and changes in the intestinal microbiome in mouse models of liver diseaseJournal of Hepatology, 2012
- Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in miceJournal of Hepatology, 2012
- Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gutThe Journal of Physiology, 2012
- Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cellsJournal of Hepatology, 2011
- Gut Microbiota Dysbiosis Is Associated with Inflammation and Bacterial Translocation in Mice with CCl4-Induced FibrosisPLOS ONE, 2011
- Diet Drives Convergence in Gut Microbiome Functions Across Mammalian Phylogeny and Within HumansScience, 2011
- An ecological and evolutionary perspective on human–microbe mutualism and diseaseNature, 2007
- Mesenteric lymph nodes at the center of immune anatomyJournal of Experimental Medicine, 2006
- Host-Bacterial Mutualism in the Human IntestineScience, 2005